Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.650
-0.030 (-1.79%)
May 29, 2026, 4:00 PM EDT - Market closed
Pulmonx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 88.55 | 90.5 | 83.79 | 68.68 | 53.66 | 48.42 | |
Revenue Growth (YoY) | 1.23% | 8.01% | 22.01% | 27.98% | 10.84% | 47.91% |
Cost of Revenue | 21.7 | 23.36 | 21.79 | 17.92 | 13.8 | 12.79 |
Gross Profit | 66.84 | 67.14 | 62 | 50.75 | 39.87 | 35.63 |
Selling, General & Admin | 99.26 | 101.31 | 102.14 | 94.61 | 83.11 | 69.87 |
Research & Development | 19.63 | 19.49 | 17.57 | 18.08 | 15.4 | 13.06 |
Total Operating Expenses | 118.9 | 120.8 | 119.71 | 112.69 | 98.5 | 82.93 |
Operating Income | -52.06 | -53.66 | -57.7 | -61.94 | -58.64 | -47.3 |
Interest Income | 2.14 | 2.65 | 5.06 | 5.57 | 1.53 | 0.4 |
Interest Expense | -3.35 | -3.16 | -3.51 | -3.23 | -1.07 | -0.83 |
Other Non-Operating Income (Expense) | 0.7 | 0.79 | 0.26 | -0.67 | -0.4 | -0.59 |
Total Non-Operating Income (Expense) | -0.51 | 0.29 | 1.81 | 1.66 | 0.07 | -1.01 |
Pretax Income | -52.57 | -53.38 | -55.89 | -60.27 | -58.57 | -48.32 |
Provision for Income Taxes | 0.64 | 0.63 | 0.5 | 0.57 | 0.35 | 0.34 |
Net Income | -53.21 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Net Income to Common | -53.21 | -54 | -56.39 | -60.84 | -58.92 | -48.66 |
Shares Outstanding (Basic) | 41 | 41 | 39 | 38 | 37 | 36 |
Shares Outstanding (Diluted) | 41 | 41 | 39 | 38 | 37 | 36 |
Shares Change (YoY) | 4.38% | 4.03% | 2.99% | 2.37% | 2.68% | 254.74% |
EPS (Basic) | -1.30 | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
EPS (Diluted) | -1.30 | -1.33 | -1.44 | -1.60 | -1.59 | -1.35 |
Shares Outstanding | 42.24 | 41.67 | 39.79 | 38.52 | 37.56 | 36.93 |
Free Cash Flow | -29.41 | -32.83 | -32.98 | -38.42 | -46.4 | -45.06 |
Free Cash Flow Per Share | -0.71 | -0.81 | -0.84 | -1.01 | -1.25 | -1.25 |
Gross Margin | 75.49% | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
Operating Margin | -58.79% | -59.30% | -68.87% | -90.19% | -109.27% | -97.70% |
Profit Margin | -60.09% | -59.67% | -67.30% | -88.60% | -109.80% | -100.51% |
FCF Margin | -33.22% | -36.28% | -39.37% | -55.94% | -86.47% | -93.07% |
EBITDA | -51.06 | -52.61 | -56.21 | -60.39 | -57.12 | -46.44 |
EBITDA Margin | -57.67% | -58.13% | -67.09% | -87.93% | -106.45% | -95.91% |
EBIT | -52.06 | -53.66 | -57.7 | -61.94 | -58.64 | -47.3 |
EBIT Margin | -58.79% | -59.30% | -68.87% | -90.19% | -109.27% | -97.70% |
Effective Tax Rate | -1.22% | -1.17% | -0.89% | -0.95% | -0.60% | -0.71% |